The combination of Bleomycin with TRAIL agonists or PKC inhibitors sensitizes solid tumor cells to BLM-mediated apoptosis: new strategies to overcome chemotherapy resistance of tumors
Crossref DOI link: https://doi.org/10.1007/s00044-017-1915-9
Published Online: 2017-05-19
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brahim, Souhir
Aroui, Sonia
Ali, Rahamata
Jeannin, Jean F.
Kenani, Abderraouf
Bettaieb, Ali
License valid from 2017-05-19